HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Distinct effects of mycophenolate mofetil and cyclophosphamide on renal fibrosis in NZBWF1/J mice.

Abstract
Progression to chronic renal failure varies between patients with lupus nephritis. We compared the effects of mycophenolate mofetil (MMF) and cyclophosphamide (CTX), on renal histology and cellular pathways of fibrosis in murine lupus nephritis. Female NZBWF1/J mice were randomized to treatment with vehicle, methylprednisolone (MP) alone, MMF + MP or CTX + MP for up to 12 weeks, and the effects on clinical parameters, renal histology, and fibrotic processes were investigated. Treatment with MMF + MP or CTX + MP both improved survival, renal function, and decreased anti-dsDNA antibody level and immune complex deposition in kidneys of mice with active nephritis. Vehicle-treated mice showed progressive increase in mesangial proliferation, inflammatory cell infiltration and renal tubular atrophy, associated with PKC-α activation, increased TGF-β1 expression and increased matrix protein deposition. MP treatment alone did not have any significant effect. MMF + MP or CTX + MP treatment for 12 weeks reduced these abnormalities. MMF + MP was more effective than CTX + MP in suppressing fibrotic mediators, histological fibrosis score and expression of TGF-β1, fibronectin and collagen I in the kidney. Results from in vitro experiments on human mesangial cells (HMC) showed that mycophenolic acid (MPA) was more effective than CTX in suppressing PKC-α activation and TGF-β1 secretion induced by human polyclonal anti-dsDNA antibodies. While both MPA and CTX decreased TGF-β1- and TNF-α-induced fibronectin synthesis, only MPA decreased IL-6 induced fibronectin synthesis. MPA and CTX show distinct effects on fibrotic and inflammatory processes in NZBWF1/J murine lupus nephritis, suggesting that MMF + MP may be more effective than CTX + MP in preserving normal renal histology in lupus nephritis.
AuthorsSusan Yung, Qing Zhang, Mel K M Chau, Tak Mao Chan
JournalAutoimmunity (Autoimmunity) Vol. 48 Issue 7 Pg. 471-87 ( 2015) ISSN: 1607-842X [Electronic] England
PMID26099989 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Anti-Inflammatory Agents, Non-Steroidal
  • Fibronectins
  • Immunosuppressive Agents
  • Interleukin-6
  • Transforming Growth Factor beta1
  • interleukin-6, mouse
  • Cyclophosphamide
  • Protein Kinase C-alpha
  • Mycophenolic Acid
  • Methylprednisolone
Topics
  • Animals
  • Anti-Inflammatory Agents, Non-Steroidal (pharmacology)
  • Cell Proliferation (drug effects)
  • Cyclophosphamide (pharmacology)
  • Disease Models, Animal
  • Disease Progression
  • Female
  • Fibronectins (antagonists & inhibitors, genetics, immunology)
  • Fibrosis
  • Gene Expression Regulation
  • Humans
  • Immunosuppressive Agents (pharmacology)
  • Interleukin-6 (antagonists & inhibitors, genetics, immunology)
  • Kidney (drug effects, immunology, pathology)
  • Kidney Function Tests
  • Lupus Nephritis (drug therapy, immunology, mortality, pathology)
  • Male
  • Mesangial Cells (drug effects, immunology, pathology)
  • Methylprednisolone (pharmacology)
  • Mice
  • Mycophenolic Acid (analogs & derivatives, pharmacology)
  • Protein Kinase C-alpha (antagonists & inhibitors, genetics, immunology)
  • Survival Analysis
  • Transforming Growth Factor beta1 (antagonists & inhibitors, genetics, immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: